Evidence map›Paper›PMID 33251507›Full record

ArticleKidney medicine

COVID-19 and Survival in Maintenance Dialysis.

John J Sim, Cheng-Wei Huang, David C Selevan, Joanie Chung, Mark P Rutkowski, Hui Zhou

Abstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Response to and outcomes of the Pfizer BNT162B2 vaccine in hemodialysis patients-A prospective observational study.Hemodialysis international. International Symposium on Home Hemodialysis · 2022
    Observational
  10. COVID-19 Survival and its impact on chronic kidney disease.Translational research : the journal of laboratory and clinical medicine · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. [Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines].Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

John J SimDivision of Nephrology and Hypertension, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
Cheng-Wei HuangDepartment of Hospital Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA.
David C SelevanRenal Business Group, Kaiser Permanente Southern California, Pasadena, CA.
Joanie ChungDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
Mark P RutkowskiRenal Business Group, Kaiser Permanente Southern California, Pasadena, CA.
Hui ZhouDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33251507
PMCPMC7685033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.